| Code | 8189E | ||||||||||
| MA number | 19/0315/24-S | ||||||||||
| Product Form: | sol inj 10x2 ml/200 mg (liek.inj.skl.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | ONKOGEN Kft., Hungary | ||||||||||
| Therapeutic Class: | 19 - ANTIDOTA, DETOXICANTIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA renewed: | Renewal application submitted |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_Sugammadex Onkogen_12.2024.pdf
|
| SPC: |
SPC_Sugammadex Onkogen_12.2024.pdf
|
| Safety feature | Yes |
| Data update: | 25.11.2024 |
